Since these factors could modify the relationship between TG/HDL-C ratio and Pre-DM, it is clinically possible to reduce the risk of Pre-DM by altering the strength of the association between the TG/HDL-C ratio and Pre-DM through interfering with BMI and ALT levels. This evidence concerns the gene GPT and diabetes mellitus.